Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters

Database
Country/Region as subject
Language
Publication year range
1.
Cell Mol Immunol ; 18(12): 2588-2608, 2021 12.
Article in English | MEDLINE | ID: mdl-34728796

ABSTRACT

Since severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-specific T cells have been found to play essential roles in host immune protection and pathology in patients with coronavirus disease 2019 (COVID-19), this study focused on the functional validation of T cell epitopes and the development of vaccines that induce specific T cell responses. A total of 120 CD8+ T cell epitopes from the E, M, N, S, and RdRp proteins were functionally validated. Among these, 110, 15, 6, 14, and 12 epitopes were highly homologous with SARS-CoV, OC43, NL63, HKU1, and 229E, respectively; in addition, four epitopes from the S protein displayed one amino acid that was distinct from the current SARS-CoV-2 variants. Then, 31 epitopes restricted by the HLA-A2 molecule were used to generate peptide cocktail vaccines in combination with Poly(I:C), R848 or poly (lactic-co-glycolic acid) nanoparticles, and these vaccines elicited robust and specific CD8+ T cell responses in HLA-A2/DR1 transgenic mice as well as wild-type mice. In contrast to previous research, this study established a modified DC-peptide-PBL cell coculture system using healthy donor PBMCs to validate the in silico predicted epitopes, provided an epitope library restricted by nine of the most prevalent HLA-A allotypes covering broad Asian populations, and identified the HLA-A restrictions of these validated epitopes using competitive peptide binding experiments with HMy2.CIR cell lines expressing the indicated HLA-A allotype, which initially confirmed the in vivo feasibility of 9- or 10-mer peptide cocktail vaccines against SARS-CoV-2. These data will facilitate the design and development of vaccines that induce antiviral CD8+ T cell responses in COVID-19 patients.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , COVID-19 Vaccines/immunology , Epitopes, T-Lymphocyte/immunology , SARS-CoV-2/immunology , Animals , Cell Line , Drug Evaluation, Preclinical , Female , HLA-A2 Antigen/immunology , Humans , Immunogenicity, Vaccine , Mice , Mice, Inbred C57BL , Mice, Transgenic , Peptide Library , Vaccine Development
2.
Sci Rep ; 11(1): 9081, 2021 04 27.
Article in English | MEDLINE | ID: mdl-33907268

ABSTRACT

Phosphorus-solubilizing microorganisms is a microbial fertilizer with broad application potential. In this study, 7 endophytic phosphate solubilizing bacteria were screened out from Chinese fir, and were characterized for plant growth-promoting traits. Based on morphological and 16S rRNA sequence analysis, the endophytes were distributed into 5 genera of which belong to Pseudomonas, Burkholderia, Paraburkholderia, Novosphingobium, and Ochrobactrum. HRP2, SSP2 and JRP22 were selected based on their plant growth-promoting traits for evaluation of Chinese fir growth enhancement. The growth parameters of Chinese fir seedlings after inoculation were significantly greater than those of the uninoculated control group. The results showed that PSBs HRP2, SSP2 and JRP22 increased plant height (up to 1.26 times), stem diameter (up to 40.69%) and the biomass of roots, stems and leaves (up to 21.28%, 29.09% and 20.78%) compared to the control. Total N (TN), total P (TP), total K (TK), Mg and Fe contents in leaf were positively affected by PSBs while showed a significant relationship with strain and dilution ratio. The content of TN, TP, TK, available phosphorus (AP) and available potassium (AK) in the soil increased by 0.23-1.12 mg g-1, 0.14-0.26 mg g-1, 0.33-1.92 mg g-1, 5.31-20.56 mg kg-1, 15.37-54.68 mg kg-1, respectively. Treatment with both HRP2, SSP2 and JRP22 increased leaf and root biomass as well as their N, P, K uptake by affecting soil urease and acid phosphatase activities, and the content of available nutrients in soil. In conclusion, PSB could be used as biological agents instead of chemical fertilizers for agroforestry production to reduce environmental pollution and increase the yield of Chinese fir.


Subject(s)
Agricultural Inoculants/physiology , Cunninghamia/growth & development , Cunninghamia/microbiology , Phosphates/metabolism , Seedlings/growth & development , Bacteria/genetics , Bacteria/metabolism , Bacterial Proteins/metabolism , Carbon-Carbon Lyases/metabolism , Cunninghamia/metabolism , Endophytes/physiology , Indoleacetic Acids/metabolism , Nitrogenase/metabolism , Phosphorus/metabolism , RNA, Ribosomal, 16S , Seedlings/metabolism , Seedlings/microbiology , Siderophores/metabolism , Soil/chemistry
3.
Environ Pollut ; 240: 353-358, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29751331

ABSTRACT

A novel mobile laser radar system was used for mapping gaseous atomic mercury (Hg0) atmospheric pollution in the Wanshan district, south of Tongren City, Guizhou Province, China. This area is heavily impacted by legacy mercury from now abandoned mining activities. Differential absorption lidar measurements were supplemented by localized point monitoring using a Lumex RA-915M Zeeman modulation mercury analyzer. Range-resolved concentration measurements in different directions were performed. Concentrations in the lower atmospheric layers often exceeded levels of 100 ng/m3 for March conditions with temperature ranging from 5 °C to 20 °C. A flux measurement of Hg0 over a vertical cross section of 0.12 km2 resulted in about 29 g/h. Vertical lidar sounding at night revealed quickly falling Hg0 concentrations with height. This is the first lidar mapping demonstration in a heavily mercury-polluted area in China, illustrating the lidar potential in complementing point monitors.


Subject(s)
Air Pollutants/analysis , Environmental Monitoring/methods , Mercury/analysis , Atmosphere/chemistry , China , Environmental Pollution , Mining , Remote Sensing Technology
4.
Hum Vaccin Immunother ; 12(3): 829-36, 2016 03 03.
Article in English | MEDLINE | ID: mdl-26479036

ABSTRACT

The rapid occurrence of emerging infectious diseases demonstrates an urgent need for a new preclinical experimental model that reliably replicates human immune responses. Here, a new homozygous humanized human leukocyte antigen (HLA)-A11/DR1 transgenic mouse (HLA-A11(+/+)/DR01(+/+)/H-2-ß2m(-/-)/IAß(-/-)) was generated by crossing HLA-A11 transgenic (Tg) mice with HLA-A2(+/+)/DR01(+/+)/H-2-ß2m(-/-)/IAß(-/-) mice. The HLA-A11-restricted immune response of this mouse model was then examined. HLA-A11 Tg mice expressing a chimeric major histocompatibility complex (MHC) molecule comprising the α1, α2, and ß2m domains of human HLA-A11 and the α3 transmembrane and cytoplasmic domains of murine H-2D(b) were generated. The correct integration of HLA-A11 and HLA-DR1 into the genome of the HLA-A11/DR1 Tg mice (which lacked the expression of endogenous H-2-I/II molecules) was then confirmed. Immunizing mice with a recombinant HBV vaccine or a recombinant HIV-1 protein resulted in the generation of IFN-γ-producing cytotoxic T lymphocyte (CTL) and antigen-specific antibodies. The HLA-A11-restricted CTL response was directed at HLA immunodominant epitopes. These mice represent a versatile animal model for studying the immunogenicity of HLA CTL epitopes in the absence of a murine MHC response. The established animal model will also be useful for evaluating and optimizing T cell-based vaccines and for studying differences in antigen processing between mice and humans.


Subject(s)
AIDS Vaccines/immunology , Drug Evaluation, Preclinical/methods , HLA-A11 Antigen/genetics , HLA-DR1 Antigen/genetics , Hepatitis B Vaccines/immunology , Mice, Transgenic , AIDS Vaccines/administration & dosage , Animals , Crosses, Genetic , HIV Antibodies/blood , Hepatitis B Antibodies/blood , Hepatitis B Vaccines/administration & dosage , Homozygote , Humans , Interferon-gamma/metabolism , Models, Animal , T-Lymphocytes/immunology
5.
Virol J ; 10: 266, 2013 Aug 26.
Article in English | MEDLINE | ID: mdl-23978242

ABSTRACT

BACKGROUND: Evidence points to the emergence of a novel human coronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), which causes a severe acute respiratory syndrome (SARS)-like disease. In response, the development of effective vaccines and therapeutics remains a clinical priority. To accomplish this, it is necessary to evaluate neutralizing antibodies and screen for MERS-CoV entry inhibitors. METHODS: In this study, we produced a pseudovirus bearing the full-length spike (S) protein of MERS-CoV in the Env-defective, luciferase-expressing HIV-1 backbone. We then established a pseudovirus-based inhibition assay to detect neutralizing antibodies and anti-MERS-CoV entry inhibitors. RESULTS: Our results demonstrated that the generated MERS-CoV pseudovirus allows for single-cycle infection of a variety of cells expressing dipeptidyl peptidase-4 (DPP4), the confirmed receptor for MERS-CoV. Consistent with the results from a live MERS-CoV-based inhibition assay, the antisera of mice vaccinated with a recombinant protein containing receptor-binding domain (RBD, residues 377-662) of MERS-CoV S fused with Fc of human IgG exhibited neutralizing antibody response against infection of MERS-CoV pseudovirus. Furthermore, one small molecule HIV entry inhibitor targeting gp41 (ADS-J1) and the 3-hydroxyphthalic anhydride-modified human serum albumin (HP-HSA) could significantly inhibit MERS-CoV pseudovirus infection. CONCLUSION: Taken together, the established MERS-CoV inhibition assay is a safe and convenient pseudovirus-based alternative to BSL-3 live-virus restrictions and can be used to rapidly screen MERS-CoV entry inhibitors, as well as evaluate vaccine-induced neutralizing antibodies against the highly pathogenic MERS-CoV.


Subject(s)
Antibodies, Neutralizing/isolation & purification , Antibodies, Viral/isolation & purification , Antiviral Agents/isolation & purification , Coronavirus/drug effects , Coronavirus/immunology , Drug Evaluation, Preclinical/methods , Neutralization Tests/methods , Animals , Cell Line , HIV-1/genetics , Humans , Luciferases/analysis , Luciferases/genetics , Mice , Spike Glycoprotein, Coronavirus/genetics , Spike Glycoprotein, Coronavirus/metabolism , Staining and Labeling/methods
6.
J Am Chem Soc ; 128(41): 13575-85, 2006 Oct 18.
Article in English | MEDLINE | ID: mdl-17031972

ABSTRACT

Alpha-hydrogen abstraction and alpha-hydrogen migration reactions yield novel titanium(IV) complexes bearing terminal phosphinidene ligands. Via an alpha-H migration reaction, the phosphinidene ((tBu)nacnac)Ti=P[Trip](CH(2)(tBu) ((tBu)nacnac(-) = [Ar]NC((t)Bu)CHC((t)Bu)N[Ar], Ar = 2,6-(CHMe2)(2C6H3, Trip = 2,4,6-(i)Pr3C6H2) was prepared by the addition of the primary phosphide LiPH[Trip] to the nucleophilic alkylidene triflato complex ((tBu)nacnac)Ti=CH(t)Bu(OTf), while alpha-H abstraction was promoted by the addition of LiPH[Trip] to the dimethyl triflato precursor ((tBu)nacnac)Ti(CH)(2)(OTf) to afford ((tBu)nacnac)Ti=P[Trip](CH3). Treatment of ((tBu)nacnac)Ti=P[Trip](CH3) with B(C6F5)(3) induces methide abstraction concurrent with formation of the first titanium(IV) phosphinidene zwitterion complex ((tBu)nacnac)Ti=P[Trip]{CH3B(C6F5)(3)}. Complex ((tBu)nacnac)Ti=P[Trip]{CH3B(C6F5)(3)} [2 + 2] cycloadds readily PhCCPh to afford the phosphametallacyclobutene [((tBu)nacnac)Ti(P[Trip]PhCCPh)][CH3B(C6F5)(3)]. These titanium(IV) phosphinidene complexes possess the shortest Ti=P bonds reported, have linear phosphinidene groups, and reveal significantly upfielded solution 31P NMR spectroscopic resonances for the phosphinidene phosphorus. Solid state 31P NMR spectroscopic data also corroborate with all three complexes possessing considerably shielded chemical shifts for the linear and terminal phosphinidene functionality. In addition, high-level DFT studies on the phosphinidenes suggest the terminal phosphinidene linkage to be stabilized via a pseudo Ti[triple bond]P bond. Linearity about the Ti-P-C(ipso) linkage is highly dependent on the sterically encumbering substituents protecting the phosphinidene. Complex ((tBu)nacnac)Ti=P[Trip]{CH3B(C6F5))(3)} can catalyze the hydrophosphination of PhCCPh with H(2)PPh to produce the secondary vinylphosphine HP[Ph]PhC=CHPh. In addition, we demonstrate that this zwitterion is a powerful phospha-Staudinger reagent and can therefore act as a carboamination precatalyst of diphenylacetylene with aldimines.


Subject(s)
Algorithms , Organometallic Compounds/chemistry , Phosphines/chemistry , Phosphorus/chemistry , Titanium/chemistry , Acetylene/analogs & derivatives , Acetylene/chemistry , Aldehydes/chemistry , Amination , Carbonates/chemistry , Catalysis , Hydrogen/chemistry , Imines/chemistry , Ligands , Magnetic Resonance Spectroscopy , Models, Theoretical
SELECTION OF CITATIONS
SEARCH DETAIL